title: Potential chemotherapy options in the triple negative subtype of breast cancer.
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Hakan
authors.initials: H
authors.lastname: Harputluoglu
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Ibrahim H
authors.initials: IH
authors.lastname: Gullu
mesh_terms: D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D051242:Caveolin 1 / Q000502:physiology; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
chemical_list: D051242:Caveolin 1; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone